Genetic polymorphisms in MMP 2, 3 and 9 genes and the susceptibility of osteosarcoma in a Chinese Han population

被引:9
作者
Cui, Yan [1 ]
Zhu, Jia-Jun [1 ]
Ma, Cheng-bin [1 ]
Cui, Kai [1 ]
Wang, Feng [1 ]
Ni, Sheng-Hui [1 ]
Zhang, Zhi-Yu [1 ]
机构
[1] China Med Univ, Affiliated Hosp 4, Dept Orthopaed, 4 Chongshandong Rd, Shenyang 110000, Liaoning, Peoples R China
关键词
single-nucleotide polymorphism; MMPs; susceptibility; osteosarcoma; MATRIX METALLOPROTEINASES; INCREASED EXPRESSION; COLORECTAL-CANCER; MATRIX-METALLOPROTEINASE-9; METASTASIS; INVASION; INHIBITORS; CARCINOMA;
D O I
10.3109/1354750X.2015.1118550
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: There are no data about the role of MMPs polymorphism in development of osteosarcoma. Patients and methods: Two-hundred fifty-one patients with osteosarcoma and 251 healthy controls were included to investigate the association between the MMP2, 3, 9 polymorphisms and the risk of osteosarcoma. Results: Compared with the MMP2 SNP rs243865 homozygote CC, The heterozygous CT genotype was associated with significantly increased risk for osteosarcoma (OR = 1.86, 95% CI = 1.18-4.22, p = 0.014); the TT genotype was associated with increased risk for osteosarcoma (OR = 1.92, 95% CI = 1.21-3.52, p = 0.028). However, the genotype and allele frequencies of MMP3 rs3025058 and MMP9 rs3918242 polymorphisms were not significantly different. Conclusion: MMP2 rs243865 genotype was associated with increased risk for development of osteosarcoma in Chinese Han population.
引用
收藏
页码:160 / 163
页数:4
相关论文
共 22 条
[1]   Predictive Impact of Common Variations in DNA Repair Genes on Clinical Outcome of Osteosarcoma [J].
Bai, Sheng-Bin ;
Chen, Hong-Xiang ;
Bao, Yong-Xing ;
Luo, Xue-Gang ;
Zhong, Jin-Jie .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) :3677-3680
[2]  
Cho Soo-Jin, 2015, Surg Pathol Clin, V8, P419, DOI 10.1016/j.path.2015.05.004
[3]   Chemotherapy resistance in osteosarcoma: current challenges and future directions [J].
Chou, Alexander J. ;
Gorlick, Richard .
EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (07) :1075-1085
[4]   Matrix metalloproteinases and tumor metastasis [J].
Deryugina, EI ;
Quigley, JP .
CANCER AND METASTASIS REVIEWS, 2006, 25 (01) :9-34
[5]   Metalloproteinases: role in breast carcinogenesis, invasion and metastasis [J].
Duffy, MJ ;
Maguire, TM ;
Hill, A ;
McDermott, E ;
O'Higgins, N .
BREAST CANCER RESEARCH, 2000, 2 (04) :252-257
[6]   Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck - Correlation with p53 status, inducible nitric oxide synthase activity, and anigogenesis [J].
Franchi, A ;
Santucci, M ;
Masini, E ;
Sardi, I ;
Paglierani, M ;
Gallo, O .
CANCER, 2002, 95 (09) :1902-1910
[7]  
Freije JMP, 2003, ADV EXP MED BIOL, V532, P91
[8]  
Kallakury BVS, 2001, CLIN CANCER RES, V7, P3113
[9]   Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer [J].
Kim, Tae-Dong ;
Song, Kyoung-Sub ;
Li, Ge ;
Choi, Hoon ;
Park, Hae-Duck ;
Lim, Kyu ;
Hwang, Byung-Doo ;
Yoon, Wan-Hee .
BMC CANCER, 2006, 6 (1)
[10]  
Kramarova E, 1996, INT J CANCER, V68, P759